Component

Human alpha7 nicotinic acetylcholine receptor / CHRNA7

Homopentameric ligand-gated cation channel.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. Preapplication of ivermectin in the micromolar range strongly enhanced the acetylcholine-evoked current of alpha7 nicotinic acetylcholine receptors, acting as a positive allosteric effector.

    Experimental context and source evidence
    duration
    Acute
    evidence_access
    Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
    experimental_model
    Chick and human alpha7 nicotinic acetylcholine receptors in Xenopus laevis oocytes and K-28 cells
    exposure
    Micromolar ivermectin preapplication
    limitations
    Micromolar exposure in a heterologous expression system is well above ordinary antiparasitic plasma concentrations, and the authors exclude a nonspecific chloride current rather than establishing an in vivo effect.
    organism
    Chick and human alpha7 nicotinic acetylcholine receptors in Xenopus laevis oocytes and K-28 cells
    plain_language
    Preapplication of ivermectin in the micromolar range strongly enhanced the acetylcholine-evoked current of alpha7 nicotinic acetylcholine receptors, acting as a positive allosteric effector.
    primary_references
    Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor. (1998). https://pubmed.ncbi.nlm.nih.gov/9463487/ DOI: 10.1124/mol.53.2.283
    route
    In vitro
    tissue
    Ligand-gated cation channel current

    Ivermectin: mechanism of action across parasite, host barrier and mammalian targets (2026-09-22) · lines 79–88

    Original AI-assisted curation of sixteen primary studies resolved by PubMed title search and cross-checked against live PubMed metadata. Study-specific citations, concentrations, negative findings and limitations retained. Not publisher full text. · supports · · source_derived_draft · unverified_draft

    ## ivermectin-alpha7-nicotinic-potentiation Preapplication of ivermectin in the micromolar range strongly enhanced the acetylcholine-evoked current of alpha7 nicotinic acetylcholine receptors, acting as a positive allosteric effector. Model/species: Chick and human alpha7 nicotinic acetylcholine receptors in Xenopus laevis oocytes and K-28 cells Tissue/system: Ligand-gated cation channel current Exposure: Micromolar ivermectin preapplication Route: In vitro Duration: Acute Limits: Micromolar exposure in a heterologous expression system is well above ordinary antiparasitic plasma concentrations, and the authors exclude a nonspecific chloride current rather than establishing an in vivo effect. Primary reference: Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor. (1998). https://pubmed.ncbi.nlm.nih.gov/9463487/ DOI: 10.1124/mol.53.2.283 Access: Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards